West Pharma (WST) Tops Q2 EPS by 33c, provides guidance
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $342.45 +1.12%
Revenue Growth %: +2.5%
Financial Fact:
Gross profit: 121.1M
Today's EPS Names:
RCBC, GASS, YSG, More
Revenue Growth %: +2.5%
Financial Fact:
Gross profit: 121.1M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q2 EPS of $1.84, $0.33 better than the analyst estimate of $1.51. Revenue for the quarter came in at $766.5 million versus the consensus estimate of $725.26 million.
GUIDANCE:
West Pharma sees FY2025 EPS of $6.65-$6.85, versus the consensus of $6.27.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Meta unveils Muse Spark 1.3 with coding improvements
- MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
